Health Care Equipment & Supplies Companies By Ps Ratio

Price To Sales
Price To SalesEfficiencyMarket RiskExp Return
1ZTEK ZEN Graphene Solutions
2.15 K
 0.07 
 5.07 
 0.36 
2GUTS Fractyl Health, Common
1.42 K
 0.10 
 10.21 
 0.99 
3DARE Dare Bioscience
901.81
(0.06)
 2.19 
(0.13)
4DXR Daxor
389.22
 0.10 
 2.81 
 0.29 
5BFRG Bullfrog AI Holdings,
262.62
 0.02 
 8.21 
 0.16 
6MGRM Monogram Orthopaedics Common
243.53
 0.03 
 3.50 
 0.11 
7HSCS Heart Test Laboratories
202.07
 0.11 
 5.75 
 0.63 
8CATX Perspective Therapeutics
192.26
 0.15 
 7.37 
 1.10 
9COCH Envoy Medical
145.87
 0.05 
 3.99 
 0.19 
10NXL Nexalin Technology
133.03
(0.19)
 4.79 
(0.90)
11AVR Anteris Technologies Global
101.59
 0.06 
 9.45 
 0.54 
12AIMD Ainos Inc
100.16
 0.02 
 6.71 
 0.11 
13PTHL Pheton Holdings Ltd
97.29
 0.29 
 10.47 
 3.05 
14ACON Aclarion
75.55
(0.12)
 5.81 
(0.67)
15SCIE Spectrascience New
73.07
 0.00 
 0.00 
 0.00 
16NYXH Nyxoah
68.14
 0.03 
 3.95 
 0.11 
17AHG Akso Health Group
61.47
 0.05 
 6.91 
 0.34 
18VNRX Volitionrx
60.77
 0.11 
 6.97 
 0.74 
19PLSE Pulse Biosciences
60.23
(0.03)
 3.51 
(0.12)
20BJDX Bluejay Diagnostics
54.99
 0.00 
 18.51 
 0.07 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries. The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.